US poised to issue rule subjecting Chinese biotech licensing deals to added Treasury scrutiny

The US is poised to issue a proposed rule that would subject outbound licensing deals with Chinese biotech companies to additional Treasury scrutiny, with draft outbound investment rules expected Thursday.

Detected & updated continuously · Source: Nebula